Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03496025
Other study ID # R15067
Secondary ID
Status Active, not recruiting
Phase Phase 1
First received
Last updated
Start date August 1, 2015
Est. completion date May 31, 2021

Study information

Verified date September 2019
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose of the trial is to study the activations of paralyzed facial muscles in a unilateral facial nerve palsy with a multi-channel electrical stimulator. The principle of the device is to measure muscle activity of the healthy side of the face by surface electromyography (EMG) and to use this information to stimulate the corresponding muscles of the paralyzed side. The ultimate goal is to develop a prosthetic device for persons with a facial nerve palsy. The trial consists of several different studies. The studies' aims are 1. To study activations of paralyzed facial muscles by the electrical stimulation. 2. To study different stimulation pulse waveforms, frequencies, and electrode placement and their effect on the muscle activations and the tolerability of the stimulation. 3. To study whether a symmetrical movement on the paralyzed side can be achieved with electrical stimulation when compared to the movements of the healthy side. 4. To study tolerability of stimulation-elicited eye blink when watching a film and the effect of the stimulation-induced blink on the eye symptoms, the visual acuity, and the effects of the stimulation on the lacrimal fluid. 5. To develop a method for facial pacing, i.e. measuring the muscle activations on the healthy side of the face and to use this information to stimulate and activate the healthy side of the face. Forty subjects with a chronic facial nerve palsy are recruited to the studies. Each subject can participate in one or several studies. Another forty subjects with an acute facial nerve palsy are recruited to the study on the tolerability and effect on the eye symptoms. Additionally, altogether ninety healthy volunteers are recruited to the studies in order to gather preliminary information on the tolerability and the effects of the stimulations.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 77
Est. completion date May 31, 2021
Est. primary completion date October 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - a unilateral peripheral facial nerve palsy (patients) - willingness to participate (patients, healthy volunteers) Exclusion Criteria: - malignant diseases (a previously treated cancer is not an exclusion criterion) - unstable cardiovascular disease - severe immune deficiency - other severe neurological diseases (causing cognitive or physical impairment) - diabetic neuropathy

Study Design


Intervention

Device:
Electrical muscle stimulation
The intervention consists of activating paralyzed facial muscles with electrical stimulation.

Locations

Country Name City State
Finland Tampere University Hospital Tampere

Sponsors (4)

Lead Sponsor Collaborator
Tampere University Hospital Helsinki University Central Hospital, Tampere University, Tampere University of Technology

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amplitudee of the movement elicited by electrical stimulation The offline video analysis is done to determine the current threshold at which a movement of the target muscle is produced. Possible activations of the other muscles alongside the target muscle are also observed. The amplitude of the movement is analyzed offline from a video recording either visually by the investigators, or measured with a digital ruler. With visual evaluation, the outcome is measured on a rough level, i.e. whether the stimulated movement was larger in amplitude compared to the voluntary movement. With a digital ruler, the results a presented numerically (millimeters). The stimulated activation is compared to the voluntary activation of the muscle. Further, in some sub-studies, the facial activations are evaluated with the Facial Action Coding System. Immediate
Secondary Subjective ratings related to the tolerability of stimulations The participants evaluate the experienced discomfort and painfulness of the stimulation with a numeric rating scale (NRS). Immediate
Secondary Subjective ratings related to acceptability of the stimulated movement The participants evaluate the naturalness and symmetry and their satisfaction with the stimulation elicited movement with an NRS. Immediate
Secondary Visual acuity In substudies concerning the elicitation of eye blink, The visual acuity is measured for both eyes separately with a LogMAR chart before and after the stimulation session. Immediate
Secondary Changes in lacrimal fluid In substudies concerning the elicitation of eye blink, a lacrimal fluid sample is collected before and after the stimulation session to investigate the possible effects of the stimulation in its constitution. Immediate
See also
  Status Clinical Trial Phase
Completed NCT02489162 - The Role of a Device to Evaluate the Neuromuscular Function in Assessing Muscle in Facial Paralysis Patients N/A
Completed NCT05504473 - Blink Restoration in Patients With Facial Nerve Palsy N/A
Completed NCT04353908 - Collagen Treatment in Facial Nerve Palsy N/A
Completed NCT04894513 - Electro Physiological Responses to Kabat Motor Control Re-education on Bell's Palsy: A Randomized Controlled Study N/A
Not yet recruiting NCT05167760 - Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis Phase 4